115 related articles for article (PubMed ID: 11905586)
1. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease.
Lundstam U; Herlitz J; Karlsson T; Lindén T; Wiklund O
J Intern Med; 2002 Feb; 251(2):111-8. PubMed ID: 11905586
[TBL] [Abstract][Full Text] [Related]
2. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
Rifai N; Ma J; Sacks FM; Ridker PM; Hernandez WJ; Stampfer MJ; Marcovina SM
Clin Chem; 2004 Aug; 50(8):1364-71. PubMed ID: 15155542
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study.
Klausen IC; Sjøl A; Hansen PS; Gerdes LU; Møller L; Lemming L; Schroll M; Faergeman O
Atherosclerosis; 1997 Jul; 132(1):77-84. PubMed ID: 9247362
[TBL] [Abstract][Full Text] [Related]
5. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins.
Rasouli M; Kiasari AM
Clin Chem Lab Med; 2006; 44(1):43-50. PubMed ID: 16375584
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
Liting P; Guoping L; Zhenyue C
Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
[TBL] [Abstract][Full Text] [Related]
8. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
[TBL] [Abstract][Full Text] [Related]
10. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
[TBL] [Abstract][Full Text] [Related]
11. Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease.
Katsouras CS; Karabina SA; Tambaki AP; Goudevenos JA; Michalis LK; Tsironis LD; Stroumbis CS; Elisaf MS; Sideris DA; Tselepis AD
J Cardiovasc Risk; 2001 Oct; 8(5):311-7. PubMed ID: 11702038
[TBL] [Abstract][Full Text] [Related]
12. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
[TBL] [Abstract][Full Text] [Related]
13. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
[TBL] [Abstract][Full Text] [Related]
14. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) status in coronary heart disease.
Khan MA; Baseer A
J Pak Med Assoc; 2000 Feb; 50(2):47-50. PubMed ID: 10769521
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
